Soros Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,000
| Closed | -$16.2M | – | 179 |
|
|
2025
Q1 | $16.2M | Buy |
+60,000
| New | +$16.2M | 0.24% | 91 |
|
|
2019
Q3 | – | Sell |
-40,000
| Closed | -$2.9M | – | 172 |
|
|
2019
Q2 | $2.9M | Buy |
+40,000
| New | +$2.9M | 0.07% | 112 |
|
|
2017
Q3 | – | Sell |
-7,000
| Closed | -$558K | – | 216 |
|
|
2017
Q2 | $558K | Buy |
+7,000
| New | +$558K | 0.01% | 109 |
|
|
2016
Q1 | – | Sell |
-6,000
| Closed | -$565K | – | 219 |
|
|
2015
Q4 | $565K | Buy |
+6,000
| New | +$565K | 0.01% | 163 |
|
|
2014
Q2 | – | Sell |
-3,092
| Closed | -$208K | – | 350 |
|
|
2014
Q1 | $208K | Buy |
+3,092
| New | +$208K | ﹤0.01% | 289 |
|